Clinical Investigation : Thoracic Cancer Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib
Clinical Investigation : Thoracic Cancer Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib
复制标题
DOI：
--
复制
发表时间：
2014
期刊：
影响因子：
--
通讯作者：
Gregory N. Gan;A. Weickhardt;B. Scheier;R. Doebele;Laurie E. Gaspar;Brian D. Kavanagh;D. Camidge
中科院分区：
文献类型：
--
作者：
Gregory N. Gan;A. Weickhardt;B. Scheier;R. Doebele;Laurie E. Gaspar;Brian D. Kavanagh;D. Camidge
Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib Gregory N. Gan, MD, PhD,* Andrew J. Weickhardt, MBBS, DMedSc,y Benjamin Scheier, MD,y Robert C. Doebele, MD, PhD,y Laurie E. Gaspar, MD, MBA,* Brian D. Kavanagh, MD, MPH,* and D. Ross Camidge, MD, PhDy Departments of *Radiation Oncology and yMedical Oncology, University of Colorado, Aurora, Colorado
